NCT06397092Completed
Anesthetic Management for TA-BSM in HOCM
Anesthetic Management for Transapical Beating-heart Septal Myectomy (TA-BSM) in Patients With Hypertrophic Obstructive Cardiomyopathy (HOCM)：A Retrospective Analysis
Source: ClinicalTrials.gov · Last updated 2 May 2024
Brief summary (registry, in English)
To retrospectively analyze the preoperative, intraoperative and postoperative anesthesia management of patients with hypertrophic cardiomyopathy undergoing TA-BSM in the investigators' hospital, and to provide clinical basis for the development of reasonable and standardized perioperative anesthesia program for these patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 120 (actual)
- First submitted
- 7 Apr 2024
- Start date
- 1 Apr 2022
- Primary completion date
- 31 Jan 2023
- Lead sponsor
- Tongji Hospital
- Diseases
- Hypertrophic cardiomyopathy
- NCT number
- NCT06397092
What you commit to
- Study type: Observational
- Participants enrolled: 120
- From 1 Apr 2022 to the primary completion date, 31 Jan 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Cardiopulmonary bypass was used to assist the surgery.
Who the study is looking for
- Patients with hypertrophic cardiomyopathy
- American Society of Anesthesiologists (ASA) physical status classification I-III
- Undergoing TA-BSM
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tongji Hospital, Tongji Medical College, Huazhong Science and Technology University Coordinator of this site? Confirm its status | Wuhan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.